Notice of Results
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it will release its preliminary results for the year ended 31 December 2016 on Tuesday 21 March 2017.
Analyst briefing
A briefing for analysts will take place at 10am on Tuesday 21 March 2017 at the offices of N+1 Singer, One Bartholomew Lane, London EC2N 2AX. To register, please contact Walbrook PR on 020 7933 8780 or email .
Investor briefing
A briefing for all investors will take place on Tuesday 21 March 2017 at the London Capital Club, 15 Abchurch Lane, EC4N 7BW from 4.30pm for a 4.45pm start, and will be followed by drinks. If you would like to register for the investor presentation, please contact Walbrook PR on 020 7933 8780 or email
EKF Diagnostics Holdings plc Julian Baines, CEO Richard Evans, Finance Director and COO |
00 44 29 2071 0570 |
N+1 Singer Alex Price / Alex Laughton-Scott |
00 44 20 7496 3000 |
Walbrook PR Limited |
00 44 20 7933 8780 or ekf@walbrookpr.com 00 44 7980 541 893 00 44 7584 391 303 |
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.